Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Antibodies, Monoclonal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antibodies, Blocking < Antibodies, Monoclonal < Antibodies, Monoclonal, Humanized  Facettes :

List of bibliographic references indexed by Antibodies, Monoclonal

Number of relevant bibliographic references: 512.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000654 (2019) Bartlomiej Wawrzycki [Pologne] ; Dorota Krasowska [Pologne] ; Aldona Pietrzak [Pologne] ; Ewa Wielosz [Pologne] ; Maria Majdan [Pologne] ; Torello Lotti [Italie]Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
000B53 (2019) Diego Strianese [Arabie saoudite] ; Francesca Rossi [Italie]Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.
000C84 (2019) Sara Touhami [France] ; Eléonore Diwo [France] ; Pascal Sève [France] ; Salim Trad [France] ; Philip Bielefeld [France] ; Damien Sène [France] ; Sebastien Abad [France] ; Antoine Brézin [France] ; Pierre Quartier [France] ; Isabelle Koné Paut [France] ; Michel Weber [France] ; Christophe Chiquet [France] ; Marie-Hélène Errera [France] ; Jérémie Sellam [France] ; Patrice Cacoub [France] ; Gilles Kaplanski [France] ; Laurent Kodjikian [France] ; Bahram Bodaghi [France] ; David Saadoun [France]Expert opinion on the use of biological therapy in non-infectious uveitis.
000D49 (2019) Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis]Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
000D56 (2019) Masakazu Kondo [Japon] ; Hisakata Yamada [Japon]Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
000E06 (2019) Natalia Genere [États-Unis] ; Marius N. Stan [États-Unis]Current and Emerging Treatment Strategies for Graves' Orbitopathy.
001075 (2018) E. Diwo [France] ; P. Sève [France] ; S. Trad [France] ; P. Bielefeld [France] ; D. Sène [France] ; S. Abad [France] ; A. Brézin [France] ; P. Quartier [France] ; I. Koné Paut [France] ; M. Weber [France] ; C. Chiquet [France] ; M H Errera [France] ; J. Sellam [France] ; P. Cacoub [France] ; G. Kaplanski [France] ; L. Kodjikian [France] ; B. Bodaghi [France] ; D. Saadoun [France][Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
001086 (2018) X. Grimaux [France] ; S. Leducq [France] ; P. Goupille [France] ; A. Aubourg [France] ; E. Miquelestorena-Standley [France] ; M. Samimi [France][Aphthous mouth ulcers as an initial manifestation of sécukinumab-induced inflammatory bowel disease].
001087 (2018) Fusao Komada ; Yuko Nakayama ; Kohji Takara[Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents].
001161 (2018) Kazuyuki Yoshizaki [Japon] ; Shinichi Murayama [Japon] ; Hiroki Ito [Japon] ; Tomohiro Koga [Japon]The Role of Interleukin-6 in Castleman Disease.
001166 (2018) Ali Berkant Avci [Turquie] ; Eugen Feist [Allemagne] ; Gerd Rüdiger Burmester [Allemagne]Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
001179 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.
001196 (2018) Francesca Bartoli [Italie] ; Sangmee Bae [États-Unis] ; Laura Cometi [Italie] ; Marco Matucci Cerinic [Italie] ; Daniel E. Furst [États-Unis]Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018.
001204 (2018) Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis
001215 (2018) Juanita K. Hodax ; Shara R. Bialo ; Ali Yalcindag [États-Unis]SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor.
001218 (2018) I. Serio [Italie] ; F. Tovoli [Italie]Rheumatoid arthritis: new monoclonal antibodies.
001224 (2018) Pauline Richebé [France] ; Florian Bailly [France] ; Louise Laure Mariani [France] ; Paola Sanchez Pena [France] ; Jean Michel Pedespan [France] ; Bruno Fautrel [France]Report of two cases of tocilizumab induced recurrent meningitis or meningoencephalitis.
001265 (2018) Lluís Puig [Espagne]Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
001271 (2018) Ju-Yang Jung [Corée du Sud] ; Moon-Young Kim [Corée du Sud] ; Chang-Hee Suh [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review.
001278 (2018) Rodrigo Ayres De Oliveira [Brésil] ; Iolanda M. Fierro [Brésil]New strategies for patenting biological medicines used in rheumatoid arthritis treatment.
001282 (2018) Ernest H S. Choy [Royaume-Uni] ; Leonard H. Calabrese [États-Unis]Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Antibodies, Monoclonal" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Antibodies, Monoclonal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antibodies, Monoclonal
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021